Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ISOC1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CA1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RHOH | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | PDE12 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | LRRC8C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PGP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NPDC1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ATG101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | FCRL5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CCR5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |